In the latest session, Checkpoint Therapeutics Inc (NASDAQ: CKPT) closed at $1.96 up 4.26% from its previous closing price of $1.88. In other words, the price has increased by $+0.0800 from its previous closing price. On the day, 693206 shares were traded. CKPT stock price reached its highest trading level at $2.0200 during the session, while it also had its lowest trading level at $1.8700.
Ratios:
For a deeper understanding of Checkpoint Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.10 and its Current Ratio is at 0.10.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.
On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 01 when Oliviero James F III sold 11,900 shares for $2.01 per share. The transaction valued at 23,919 led to the insider holds 369,680 shares of the business.
GRAY WILLIAM GARRETT sold 4,115 shares of CKPT for $8,024 on Feb 01. The Chief Financial Officer now owns 147,259 shares after completing the transaction at $1.95 per share. On Mar 02, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 5,483 shares for $5.00 each. As a result, the insider received 27,415 and left with 144,090 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 48.36M and an Enterprise Value of 46.59M. For the stock, the TTM Price-to-Sale (P/S) ratio is 271.29. Its current Enterprise Value per Revenue stands at 272.46 whereas that against EBITDA is -0.79.
Stock Price History:
The Beta on a monthly basis for CKPT is 0.97, which has changed by -57.48% over the last 52 weeks, in comparison to a change of 27.79% over the same period for the S&P500. Over the past 52 weeks, CKPT has reached a high of $5.58, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 2.0684, while the 200-Day Moving Average is calculated to be 2.2676.
Shares Statistics:
For the past three months, CKPT has traded an average of 963.85K shares per day and 515.69k over the past ten days. A total of 23.53M shares are outstanding, with a floating share count of 20.20M. Insiders hold about 14.14% of the company’s shares, while institutions hold 20.20% stake in the company. Shares short for CKPT as of Jan 31, 2024 were 3.43M with a Short Ratio of 3.56, compared to 4.07M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 13.84% and a Short% of Float of 15.67%.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.54 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.8, while EPS last year was -$2.29. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.38 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$2.34 and -$3.28 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$1.31, with 3 analysts recommending between -$0.58 and -$1.97.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for CKPT’s current fiscal year. The highest revenue estimate was $200k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $120k. In the same quarter a year ago, actual revenue was $192k, down -37.50% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $10.33M in the next fiscal year. The high estimate is $19.1M and the low estimate is $1.17M. The average revenue growth estimate for next year is up 8,508.30% from the average revenue estimate for this year.
